These results suggested that indirubin could restore the homeostasis of CD4+ T cells in a PTEN/AKT/mTOR signalling pathway which is important in the maintenance of CD4+ T‐cell homeostasis in ITP. This evidence concerns the gene AKT1 and autoimmune thrombocytopenic purpura.